Clinical Trial Update: PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer

View source ↗

Summary

This clinical trial investigates whether PSA biochemical response can serve as a prognostic factor in metastatic castration-sensitive prostate cancer; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-sensitive Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Prostate Cancer, Metastatic Cancer | Status: RECRUITING